Clinical Study Results
What were the results of the study?
This is a summary of the main results from this study overall. The results each
participant had might be different and are not in this summary. A full list of the
questions researchers wanted to answer can be found on the websites listed at the
end of this summary. If a full report of the study results is available, it can also be
found on these websites.
Researchers look at the results of many studies to decide which treatments work
best and are safest. Other studies may provide new information or different results.
Always talk to a doctor before making any treatment changes.
Did anifrolumab improve the participants’ lupus symptoms that were
the focus of the study?
Yes. Anifrolumab did improve the participants’ lupus symptoms when given with the
participants’ usual lupus treatment in this study.
To answer this question, the participants completed questionnaires about all of their
lupus symptoms. They did this before they got study treatment, and throughout
the study. The researchers assessed several measures of disease activity based
on each participant’s lupus symptoms. Of these disease measures, 3 make up the
British Isles Lupus Assessment Group-based Composite Lupus Assessment, also
called BICLA. The BICLA assessment also depends on if the participants continued
to take their study treatment and did not need to take any medications that were not
allowed in the study.
If the participants met all of the criteria of the BICLA assessment, they were
considered “BICLA responders”. This meant their lupus symptoms had improved.
The researchers found that at week 52 of the study:
6